Wilson, North Carolina — According to state and local development sources, SCHOTT Pharma USA plans to invest $371,000,000.00 to build out square feet of new space in Wilson. The company is creating 401 new jobs at this facility. The company plans to occupy the new space in Wilson, on or about December 1, 2024. According to the company website SCHOTT Pharma designs solutions grounded in science to ensure that medications are safe and easy to use for people around the world because human health matters. Every day, more than 4,700 people from 65 nations work at SCHOTT Pharma to contribute to global healthcare. The company has 17 manufacturing sites across major pharmaceutical hubs in Europe, the Americas and Asia. SCHOTT Pharma maintains a diverse portfolio of injectable drug containment and delivery solutions. These solutions range from prefillable glass and polymer syringes, cartridges, vials and ampoules. The company has focused on developing innovations for future technologies by: Creating over 1000 patents and technologies developed in-house, Building a state-of-the-art Research and Development Center in Switzerland, Absorbing over 130 professionals focused on Research and Development Despite being a pharmaceutical manufacturer, SCHOTT Pharma aims to become climate-neutral by 2030. The company commits to this through sustainable development approaches in the society and the environment. Based in Mainz, Germany, it is part of SCHOTT AG that falls under the Carl Zeiss Foundation. SCHOTT Pharma has over 1700 global customers, 30 of which are the leading pharmaceutical manufacturers of injectable drugs. These customers have generated combined sales of EUR 899 million in the fiscal year 2023.

To learn more about SCHOTT Pharma USA, visit http://www.schott-pharma.com/

Company Contact:
Christopher Cassidy, President
https://www.linkedin.com/in/christopher-cassidy01/
717-228-4200

SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.